Skip to main content

Deglutition Disorders clinical trials at UCSD

1 in progress, 0 open to eligible people

Showing trials for
  • QUantitative Assessment of Swallowing After Radiation (QUASAR)

    Sorry, not yet accepting patients

    To use novel methods for quantitative analysis of VFSS (videofluoroscopic swallow study, also known as modified barium swallow) to study and compare dysphagia in patients treated for head and neck carcinoma with concurrent radiation therapy and chemotherapy (cisplatin) or targeted therapy (cetuximab) vs. immunotherapy (pembrolizumab, nivolumab, or durvalumab). Our hypothesis is that pharyngeal constriction will be greater (lower ratio) with concurrent immunotherapy compared to chemotherapy, as measured by the pharyngeal constriction ratio (PCR).

    La Jolla, California and other locations

Last updated: